Works by Rickman, David S.

Results: 19

Exquisite Sensitivity of TP53 Mutant and Basal Breast Cancers to a Dose-Dense Epirubicin--Cyclophosphamide Regimen.

Published in:

PLoS Medicine, 2007, v. 4, n. 3, p. 0585, doi. 10.1371/journal.pmed.0040090

By:

Bertheau, Philippe;
Turpin, Elisabeth;
Rickman, David S.;
Espie, Marc;
Reyniés, Aurélien;
Feugeas, Jean-Paul;
Plassa, Louis-François;
Soliman, Hany;
Varna, Mariana;
De Roquancourt, Anne;
Lehmann-Che, Jacqueline;
Beuzard, Yves;
Marty, Michel;
Misset, Jean-Louis;
Janin, Anne;
De Thé, Hugues

Publication type:

Article

Comparison of the latest commercial short and long oligonucleotide microarray technologies.

Published in:

BMC Genomics, 2006, v. 7, p. 51, doi. 10.1186/1471-2164-7-51

By:

Reynies, Aurelien de;
Geromin, Daniela;
Cayuela, Jean-Michel;
Petel, Fabien;
Dessen, Philippe;
Sigaux, Francois;
Rickman, David S

Publication type:

Article

Integrating cancer genomics and proteomics in the post-genome era.

Published in:

Proteomics, 2002, v. 2, n. 1, p. 69, doi. 10.1002/1615-9861(200201)2:1<69::AID-PROT69>3.0.CO;2-8

By:

Hanash, Samir M.;
Bobek, Miroslav P.;
Rickman, David S.;
Williams, Tom;
Rouillard, Jean Marie;
Kuick, Rork;
Puravs, Eric

Publication type:

Article

569 Investigating the Role of FOXA2 During the Transition to Neuroendocrine Prostate Cancer.

Published in:

2024

By:

Garner, Richard;
Brady, Nicholas;
Dunmore, Kate;
Singh, Richa;
Bagadion, Alyssa;
Sboner, Andrea;
Elemento, Olivier;
Robinson, Brian;
Beltran, Himisha;
Rickman, David S.

Publication type:

Abstract

Temporal evolution of cellular heterogeneity during the progression to advanced AR-negative prostate cancer.

Published in:

Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-23780-y

By:

Brady, Nicholas J.;
Bagadion, Alyssa M.;
Singh, Richa;
Conteduca, Vincenza;
Van Emmenis, Lucie;
Arceci, Elisa;
Pakula, Hubert;
Carelli, Ryan;
Khani, Francesca;
Bakht, Martin;
Sigouros, Michael;
Bareja, Rohan;
Sboner, Andrea;
Elemento, Olivier;
Tagawa, Scott;
Nanus, David M.;
Loda, Massimo;
Beltran, Himisha;
Robinson, Brian;
Rickman, David S.

Publication type:

Article

N-Myc–mediated epigenetic reprogramming drives lineage plasticity in advanced prostate cancer.

Published in:

Journal of Clinical Investigation, 2019, v. 129, n. 9, p. 3924, doi. 10.1172/JCI127961

By:

Berger, Adeline;
Brady, Nicholas J.;
Bareja, Rohan;
Robinson, Brian;
Conteduca, Vincenza;
Augello, Michael A.;
Puca, Loredana;
Ahmed, Adnan;
Dardenne, Etienne;
Xiaodong Lu;
Inah Hwang;
Bagadion, Alyssa M.;
Sboner, Andrea;
Elemento, Olivier;
Paik, Jihye;
Jindan Yu;
Barbieri, Christopher E.;
Dephoure, Noah;
Beltran, Himisha;
Rickman, David S.

Publication type:

Article

N-Myc-mediated epigenetic reprogramming drives lineage plasticity in advanced prostate cancer.

Published in:

2019

By:

Berger, Adeline;
Brady, Nicholas J;
Bareja, Rohan;
Robinson, Brian D;
Conteduca, Vincenza;
Augello, Michael A;
Puca, Loredana;
Ahmed, Adnan;
Dardenne, Etienne;
Lu, Xiaodong;
Hwang, Inah;
Bagadion, Alyssa M;
Sboner, Andrea;
Elemento, Olivier;
Paik, Jihye;
Yu, Jindan;
Barbieri, Christopher E;
Dephoure, Noah;
Beltran, Himisha;
Rickman, David S

Publication type:

journal article

WNT/β-catenin pathway activation in Wilms tumors: A unifying mechanism with multiple entries?

Published in:

Genes, Chromosomes & Cancer, 2009, v. 48, n. 9, p. 816, doi. 10.1002/gcc.20686

By:

Corbin, Marie;
de Reyniès, Aurélien;
Rickman, David S.;
Berrebi, Dominique;
Boccon-Gibod, Liliane;
Cohen-Gogo, Sarah;
Fabre, Monique;
Jaubert, Francis;
Faussillon, Marine;
Yilmaz, Funda;
Sarnacki, Sabine;
Landman-Parker, Judith;
Patte, Catherine;
Schleiermacher, Gudrun;
Antignac, Corinne;
Jeanpierre, Cécile

Publication type:

Article

Distinct genomic aberrations associated with ERG rearranged prostate cancer.

Published in:

Genes, Chromosomes & Cancer, 2009, v. 48, n. 4, p. 366, doi. 10.1002/gcc.20647

By:

Demichelis, Francesca;
Setlur, Sunita R.;
Beroukhim, Rameen;
Perner, Sven;
Korbel, Jan O.;
LaFargue, Christopher J.;
Pflueger, Dorothee;
Pina, Cara;
Hofer, Matthias D.;
Sboner, Andrea;
Svensson, Maria A.;
Rickman, David S.;
Urban, Alex;
Snyder, Michael;
Meyerson, Matthew;
Lee, Charles;
Gerstein, Mark B.;
Kuefer, Rainer;
Rubin, Mark A.

Publication type:

Article

Increased translation driven by non-canonical EZH2 creates a synthetic vulnerability in enzalutamide-resistant prostate cancer.

Published in:

Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-53874-2

By:

Chatterjee, Shankha S.;
Linares, Juan F.;
Cid-Diaz, Tania;
Duran, Angeles;
Khan, Mohd. Imran K.;
Osrodek, Marta;
Brady, Nicholas J.;
Reina-Campos, Miguel;
Marzio, Antonio;
Venkadakrishnan, Varadha Balaji;
Bakht, Martin K.;
Khani, Francesca;
Mosquera, Juan Miguel;
Robinson, Brian D.;
Moyer, Jenna;
Elemento, Olivier;
Hsieh, Andrew C.;
Goodrich, David W.;
Rickman, David S.;
Beltran, Himisha

Publication type:

Article

Lineage-specific canonical and non-canonical activity of EZH2 in advanced prostate cancer subtypes.

Published in:

Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-51156-5

By:

Venkadakrishnan, Varadha Balaji;
Presser, Adam G.;
Singh, Richa;
Booker, Matthew A.;
Traphagen, Nicole A.;
Weng, Kenny;
Voss, Nathaniel C. E.;
Mahadevan, Navin R.;
Mizuno, Kei;
Puca, Loredana;
Idahor, Osasenaga;
Ku, Sheng-Yu;
Bakht, Martin K.;
Borah, Ashir A.;
Herbert, Zachary T.;
Tolstorukov, Michael Y.;
Barbie, David A.;
Rickman, David S.;
Brown, Myles;
Beltran, Himisha

Publication type:

Article

Defining cellular population dynamics at single-cell resolution during prostate cancer progression.

Published in:

eLife, 2022, p. 1, doi. 10.7554/eLife.79076

By:

Germanos, Alexandre A.;
Arora, Sonali;
Ye Zheng;
Goddard, Erica T.;
Coleman, Ilsa M.;
Ku, Anson T.;
Wilkinson, Scott;
Song, Hanbing;
Brady, Nicholas J.;
Amezquita, Robert A.;
Zager, Michael;
Long, Annalysa;
Yu Chi Yang;
Bielas, Jason H.;
Gottardo, Raphael;
Rickman, David S.;
Huang, Franklin W.;
Ghajar, Cyrus M.;
Nelson, Peter S.;
Sowalsky, Adam G.

Publication type:

Article

AR-V7 exhibits non-canonical mechanisms of nuclear import and chromatin engagement in castrate-resistant prostate cancer.

Published in:

eLife, 2022, p. 1, doi. 10.7554/eLife.73396

By:

Seaho Kim;
Au, CheukMan C.;
Bin Jamalruddin, Mohd Azrin;
Abou-Ghali, Naira Essam;
Mukhtar, Eiman;
Portella, Luigi;
Berger, Adeline;
Worroll, Daniel;
Vatsa, Prerna;
Rickman, David S.;
Nanus, David M.;
Giannakakou, Paraskevi

Publication type:

Article

AR-V7 exhibits non-canonical mechanisms of nuclear import and chromatin engagement in castrate-resistant prostate cancer.

Published in:

eLife, 2022, p. 1, doi. 10.7554/eLife.73396

By:

Kim, Seaho;
Au, CheukMan C.;
Bin Jamalruddin, Mohd Azrin;
Abou-Ghali, Naira Essam;
Mukhtar, Eiman;
Portella, Luigi;
Berger, Adeline;
Worroll, Daniel;
Vatsa, Prerna;
Rickman, David S.;
Nanus, David M.;
Giannakakou, Paraskevi

Publication type:

Article

ERG induces taxane resistance in castration-resistant prostate cancer.

Published in:

Nature Communications, 2014, v. 5, n. 11, p. 5548, doi. 10.1038/ncomms6548

By:

Galletti, Giuseppe;
Matov, Alexandre;
Beltran, Himisha;
Fontugne, Jacqueline;
Miguel Mosquera, Juan;
Cheung, Cynthia;
MacDonald, Theresa Y.;
Sung, Matthew;
O'Toole, Sandra;
Kench, James G.;
Suk Chae, Sung;
Kimovski, Dragi;
Tagawa, Scott T.;
Nanus, David M.;
Rubin, Mark A.;
Horvath, Lisa G.;
Giannakakou, Paraskevi;
Rickman, David S.

Publication type:

Article

Extracellular Matrix in Synthetic Hydrogel‐Based Prostate Cancer Organoids Regulate Therapeutic Response to EZH2 and DRD2 Inhibitors (Adv. Mater. 2/2022).

Published in:

Advanced Materials, 2022, v. 34, n. 2, p. 1, doi. 10.1002/adma.202270014

By:

Mosquera, Matthew J.;
Kim, Sungwoong;
Bareja, Rohan;
Fang, Zhou;
Cai, Shuangyi;
Pan, Heng;
Asad, Muhammad;
Martin, Maria Laura;
Sigouros, Michael;
Rowdo, Florencia M.;
Ackermann, Sarah;
Capuano, Jared;
Bernheim, Jacob;
Cheung, Cynthia;
Doane, Ashley;
Brady, Nicholas;
Singh, Richa;
Rickman, David S.;
Prabhu, Varun;
Allen, Joshua E.

Publication type:

Article

Extracellular Matrix in Synthetic Hydrogel‐Based Prostate Cancer Organoids Regulate Therapeutic Response to EZH2 and DRD2 Inhibitors.

Published in:

Advanced Materials, 2022, v. 34, n. 2, p. 1, doi. 10.1002/adma.202100096

By:

Mosquera, Matthew J.;
Kim, Sungwoong;
Bareja, Rohan;
Fang, Zhou;
Cai, Shuangyi;
Pan, Heng;
Asad, Muhammad;
Martin, Maria Laura;
Sigouros, Michael;
Rowdo, Florencia M.;
Ackermann, Sarah;
Capuano, Jared;
Bernheim, Jacob;
Cheung, Cynthia;
Doane, Ashley;
Brady, Nicholas;
Singh, Richa;
Rickman, David S.;
Prabhu, Varun;
Allen, Joshua E.

Publication type:

Article

Optimizing spotting solutions for increased reproducibility of cDNA microarrays.

Published in:

Nucleic Acids Research, 2003, v. 31, n. 18, p. e109, doi. 10.1093/nar/gng109

By:

Rickman, David S.;
Herbert, Christopher J.;
Aggerbeck, Lawrence P.

Publication type:

Article

Identification of novel prostate cancer drivers using RegNetDriver: a framework for integration of genetic and epigenetic alterations with tissue-specific regulatory network.

Published in:

Genome Biology, 2017, v. 18, p. 1, doi. 10.1186/s13059-017-1266-3

By:

Dhingra, Priyanka;
Martinez-Fundichely, Alexander;
Berger, Adeline;
Huang, Franklin W.;
Forbes, Andre Neil;
Liu, Eric Minwei;
Liu, Deli;
Sboner, Andrea;
Tamayo, Pablo;
Rickman, David S.;
Rubin, Mark A.;
Khurana, Ekta

Publication type:

Article